Lawrence Hamel Net Worth & Insider Trades

Lawrence Hamel - Chief Development Officer, Acelrx Pharmaceuticals Inc

As of February 13, 2020

What is Lawrence Hamel's Net Worth?

The current estimated net worth of Acelrx Pharmaceuticals Inc's Chief Development Officer, Lawrence Hamel, is estimated to be about $405.89K . Lawrence Hamel owns about 107,848 units of Acelrx Pharmaceuticals Inc common stock. In the last 9 years at Acelrx Pharmaceuticals Inc, Lawrence Hamel has sold an estimated value of $294.91K worth.

What is Lawrence Hamel's Past Insider Trading?

Lawrence Hamel's largest purchase order was 3,682 units , worth over $10.35K on March 4, 2019. Lawrence Hamel's largest sale order was 10,161 units , worth over $53.75K on October 3, 2017. In total, Lawrence Hamel has made about 36 transactions over 9 years of their time at Acelrx Pharmaceuticals Inc. Lawrence Hamel usually trades in February, with the busiest year in 2014.

Lawrence Hamel

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Lawrence Hamel's' Mailing Address?

  • Mailing address is C/o Acelrx Pharmaceuticals Inc. 351 Galveston Drive Redwood City CA 94063 CA

What are Acelrx Pharmaceuticals Inc's Past Insider Trades?

Acelrx Pharmaceuticals Inc's most recent insider trade came on June 8, 2022 by Vincent Angotti who bought 46,400 units worth $10.33K . In the last 11 years, insiders at Acelrx Pharmaceuticals Inc have sold an estimated value of $23.82M and bought an estimated value of $52.86M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Lawrence Hamel, Chief Development Officer,  Badri Dasu, Chief Engineering Officer,  and Pamela Palmer, Chief Medical Officer .

ACELRX PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1